Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)

BACKGROUND: Many of the painful, disabling features of early diffuse cutaneous systemic sclerosis have an inflammatory component and are potentially treatable with corticosteroid therapy. These features include painful and itchy skin, fatigue and musculoskeletal involvement. Yet many clinicians are...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrick, Ariane L, Griffiths-Jones, Deborah J, Ryder, W David, Mason, Justin C, Denton, Christopher P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216311/
https://www.ncbi.nlm.nih.gov/pubmed/34222671
http://dx.doi.org/10.1177/2397198320957552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216311/
https://www.ncbi.nlm.nih.gov/pubmed/34222671
http://dx.doi.org/10.1177/2397198320957552

Ejemplares similares